StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ISGI.V$0.01+0.00%
Fair $0.01+0.0%

ISGI.V

InsuraGuest Technologies Inc.

Technology / Software - ApplicationTSXV

$0.01

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.01Fund rank 23/100 · Data gapFallback financials|
SA 13/F
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-294997.00 · quality 36.3/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

13/100

F

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 2.1%, below the 5% threshold
Thesis & Journal · ISGI.VLocal privado en este navegador · InsuraGuest Technologies Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

210.7%

↑

Gross Margin

83.4%

↑

Debt/Equity

N/A

•
52-Week Range$0
$0$0

TradingView lightweight chart

ISGI.V price, volumen y niveles de valoración

Último $0.010Periodo -85.7%
Fair value: $0.010

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+32.0%

FCF CAGR

—

FCF margin

-27.9%

FCF / Net income

0.55x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $793725.0 · net income $-400216.0 · FCF $-221391.0

2022-FY → 2025-FY

Gross margin

83.4%+11.3% pts

Operating margin

-50.0%+358.4% pts

Net margin

-50.4%+358.0% pts

FCF margin

-27.9%+288.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$793725.00$793725.00$699747.00$674784.00$345205.00
Net Income$-400216.00$-400216.00$-659413.00$-725961.00$-1.4M
EBITDA$-334513.00$-334513.00$-601387.00$-700899.00$-1.4M
EPS——-0.01-0.01-0.01
Gross Margin83.4%83.4%80.0%57.6%72.1%
Operating Margin-50.0%-50.0%-93.7%-108.7%-408.4%
Net Margin-50.4%-50.4%-94.2%-107.6%-408.4%
Balance Sheet
Debt/Equity——0.19——
Current Ratio0.520.52———
Cash Flow
Free Cash Flow$-221391.00$-221391.00$-294997.00$-466334.00$-1.1M
Returns
ROE210.7%210.7%-333.2%271.5%-310.7%
Valuation
P/B——10.10—15.48
Growth & Yield
Revenue Growth13.4%13.4%3.7%95.5%—
EPS Growth——-33.3%50.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -60.0%

Total return

-60.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.01 → n/d

Residual

-60.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-60.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.